Bioventus Inc. 10-Q filing
Filed 2025-08-06 · Report date 2025-06-28 · 2025
Filing metadata
- Accession number
- 0001665988-25-000017
- Form type
- 10-Q
- CIK
- 0001665988
- Primary document
- https://www.sec.gov/Archives/edgar/data/1665988/000166598825000017/bvs-20250628.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bioventus Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $271.5M | - | - |
| Cost Of Revenue | $86.4M | - | - |
| Gross Profit | $185.1M | - | - |
| Operating Income | $23.2M | - | - |
| Net Income | $4.8M | - | - |
| Eps Basic | 0.07 | - | - |
| Eps Diluted | 0.07 | - | - |
| Cash And Equivalents | $32.9M | - | - |
| Total Assets | $706.8M | - | - |
| Total Liabilities | $505.5M | - | - |
| Shareholders Equity | $161.2M | - | - |
| Operating Cash Flow | $6.6M | - | - |
| Capital Expenditures | $1.5M | - | - |